UTI Healthcare Fund vs Nippon India Pharma Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
UTI Healthcare Fund - Regular Plan - Growth Option
Chart Comparison
Overview
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹8346 Cr | ₹1125 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹500 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 05 Jun 2004 | 30 Jul 2005 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | BSE Healthcare |
| Turn Over | 21% | 28% |
| Expense Ratio | 1.82 | 2.22 |
| Manager | Sailesh Raj Bhan | Kamal Gada |
| ISIN Code | INF204K01968 | INF789F01695 |
| Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | UTI Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 1 Month | 1.53% | -0.16% |
| 6 Month | 3.31% | 5.49% |
| 1 Year | 3.77% | 3.15% |
| 3 Year | 21.72% | 24.02% |
| 5 Year | 16.93% | 16.84% |
SIP Return Analysis
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 6 Month | 0.99% | 0.26% |
| 1 Year | 8.09% | 8.84% |
| 3 Year | 18.15% | 21.42% |
| 5 Year | 17.13% | 18.66% |
Rolling Lumpsum Returns
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| 1 Year | 16.72% | 11.68% |
| 3 Year | 20.9% | 16.52% |
| 5 Year | 20.42% | 14.75% |
Risk Management
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Standard Deviation | 14.36% | 14.3% |
| Sharp | 0.95% | 1.07% |
| Beta | 0.87% | 0.89% |
| Alpha | 1.94% | 4.1% |
Fund Managers
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Name | Sailesh Raj Bhan | Kamal Gada |
| Total AUM | ₹96086 Cr | ₹870 Cr |
| Funds Managed | 5 | 1 |
| Nippon India Pharma Fund-Growth Plan-Growth Option | UTI Healthcare Fund - Regular Plan - Growth Option |
Market Cap
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Others | 1.24 | 4.96 |
| Large Cap | 32.65 | 21.02 |
| Mid Cap | 35.11 | 34.42 |
| Small Cap | 31 | 39.6 |
Sector Allocation
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
UTI Healthcare Fund - Regular Plan - Growth Option |
|---|---|---|
| Others | 0.34 | 1.88 |
| Healthcare | 99.66 | 97.05 |
| Basic Materials | - | 1.08 |
Top Comparisons
Kotak Medium Term Fund - Growth
3Y Returns8.03%
DSP Bond Fund - Growth
3Y Returns7.63%
Bandhan Banking & PSU Fund - Regular Growth
3Y Returns7.26%
Aditya Birla Sun Life Banking & PSU Debt Fund - Regular Plan-Growth
3Y Returns7.51%
ITI Banking and PSU Fund Regular - Growth
3Y Returns7.05%
LIC MF Banking & PSU Debt Fund-Growth
3Y Returns7.39%
Tata Short Term Bond Fund -Regular Plan- Growth Option
3Y Returns7.05%
Mirae Asset Short Duration Fund- Regular Plan -Growth
3Y Returns7.2%